Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.
Description
Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform.
The company is headquartered in Zürich, Switzerland.